Clinical & Experimental Metastasis

, Volume 18, Issue 2, pp 111–120 | Cite as

Tissue inhibitors of metalloproteases: Regulation and biological activities

  • Gianfranco Fassina
  • Nicoletta Ferrari
  • Claudio Brigati
  • Roberto Benelli
  • Leonardo Santi
  • Douglas M. Noonan
  • Adriana Albini
Article

Abstract

A central role in tissue invasion is played by proteases that degrade extracellular matrices; in particular specific metalloproteases (MMPs) have been frequently correlated with the invasive potential of tumor cells and with the angiogenic process. MMPs are tightly regulated by molecules controlling their activation and by specific inhibitors of MMPs, known as the Tissue Inhibitors of MetalloProteases or TIMPs. Four TIMP family members are currently known. An imbalance between MMPs and TIMPs is linked to the degradation of the extracellular matrix associated with several physiologic and pathologic events including angiogenesis, invasion and metastasis. TIMPs are not only the `guardians' of tissue degradation, they are able to control cell proliferation and cell survival as well. Given the critical role that TIMPs play, it is vital to know how the expression of TIMPs is controlled. Here we review the major biological properties and the molecular regulation of the TIMP expression.

basement membrane invasion metalloproteases TIMPs 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer 1997; 80: 1529–37.PubMedCrossRefGoogle Scholar
  2. 2.
    Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 1997; 32: 175–253.PubMedGoogle Scholar
  3. 3.
    Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43: S42–51.PubMedCrossRefGoogle Scholar
  4. 4.
    Ossowski L, Mira y Lopez R. Proteolytic enzymes in cancer invasion. Introduction. Enzyme Protein 1996; 49: 5–6.PubMedGoogle Scholar
  5. 5.
    Albini A. Tumor and endothelial cell invasion of basement membranes. Pathol Oncol Res 1998; 4: 1–12.CrossRefGoogle Scholar
  6. 6.
    Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Testa JE, Quigley JO. The role of urokinase-type plasminogen activator in aggressive tumor cell behaviour. Cancer Metastasis Rev 1990; 9: 353–67.PubMedCrossRefGoogle Scholar
  8. 8.
    Gualandris A, Lopez-Conejo T, Giunciuglio D et al. Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. Microvascular Res 1997; 53: 254–60.CrossRefGoogle Scholar
  9. 9.
    Melchiori A, Albini A, Ray JM et al. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 1992; 52: 2353–6.PubMedGoogle Scholar
  10. 10.
    Stetler-Stevenson GW, Talano J, Gallagher ME et al. Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment. Am J Med Sci 1991; 302: 163–70.PubMedGoogle Scholar
  11. 11.
    Willard HF, Durfy SJ, Mahtani MM et al. Regional localization of the TIMP gene on the human X chromosome. Extension of a conserved synteny and linkage group on proximal Xp. Hum Genet 1989; 81: 234–8.PubMedCrossRefGoogle Scholar
  12. 12.
    DeClerck Y, Szpirer C, Aly M et al. The gene for tissue inhibitor of metalloproteinases-2 (TIMP2) is localized on human chromosome arm 17q25. Genomics 1992; 14: 782–4.CrossRefGoogle Scholar
  13. 13.
    Fridman R, Fuerst TR, Bird RE et al. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 1992; 267: 15398–405.PubMedGoogle Scholar
  14. 14.
    Kurschat P, Zigrino P, Nischt R et al. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines. J Biol Chem 1999; 274: 21056–62.PubMedCrossRefGoogle Scholar
  15. 15.
    Kinoshita T, Sato H, Okada A et al. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273: 16098–103.PubMedCrossRefGoogle Scholar
  16. 16.
    Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 1994; 19: 86–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Leco KJ, Khokha R, Pavloff N et al. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994; 269: 9352–60.PubMedGoogle Scholar
  18. 18.
    Olson TM, Hirohata S, Ye J et al. Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively. Genomics 1998; 51: 148–51.PubMedCrossRefGoogle Scholar
  19. 19.
    Gomez DE, Alonso DF, Yoshiji H et al. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111–22.PubMedGoogle Scholar
  20. 20.
    Albini A, Melchiori A, Santi L et al. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991; 83: 775–9.PubMedGoogle Scholar
  21. 21.
    Albini A, Fontanini G, Masiello L et al. Angiogenic potential in vivo by Kaposi sarcoma cell-free supernatants and HIV1-tat product: inhibition of KS-like lesions by TIMP-2. AIDS 1994; 8: 1237–44.PubMedGoogle Scholar
  22. 22.
    Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27–31.PubMedCrossRefGoogle Scholar
  24. 24.
    Benelli R, Adatia R, Ensoli B et al. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol Res 1994; 6: 251–7.PubMedGoogle Scholar
  25. 25.
    Itoh T, Tanioka M, Yoshida H et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998; 58: 1048–51.PubMedGoogle Scholar
  26. 26.
    Vu TH, Shipley JM, Bergers G et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998; 93: 411–22.PubMedCrossRefGoogle Scholar
  27. 27.
    Holmbeck K, Bianco P, Caterina J et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99: 81–92.PubMedCrossRefGoogle Scholar
  28. 28.
    Albini A, Noonan D, Santi L. Angiogenesis at the interface between basic and clinical research. Int J Biol Markers 1999; 14: 202–6.PubMedGoogle Scholar
  29. 29.
    Aoudjit F, Potworowski EF, St-Pierre Y. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol 1998; 160: 2967–73.PubMedGoogle Scholar
  30. 30.
    Bugno M, Witek B, Bereta J et al. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett 1999; 448: 9–14.PubMedCrossRefGoogle Scholar
  31. 31.
    De Lorenzo MS, Alonso DF, Gomez DE. Nafoxidine modulates the expression of matrix-metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in endothelial cells. Anticancer Res 2000; 20: 395–400.PubMedGoogle Scholar
  32. 32.
    Lamoreaux WJ, Fitzgerald ME, Reiner A et al. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc Res 1998; 55: 29–42.PubMedCrossRefGoogle Scholar
  33. 33.
    Kurizaki T, Toi M, Tominaga T. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma. Oncol Rep 1998; 5: 673–7.PubMedGoogle Scholar
  34. 34.
    Lee OH, Bae SK, Bae MH et al. Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 2000; 82: 385–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Valente P, Fassina G, Melchori A et al. TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 1998; 75: 246–53.PubMedCrossRefGoogle Scholar
  36. 36.
    Kostoulas G, Lang A, Nagase H et al. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 1999; 455: 286–90.PubMedCrossRefGoogle Scholar
  37. 37.
    Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1,-2,-3, and-4) in normal and aberrant wound healing. Hum Pathol 1999; 30: 795–802.PubMedCrossRefGoogle Scholar
  38. 38.
    Hayakawa T, Yamashita K, Tanzawa K et al. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298: 29–32.PubMedCrossRefGoogle Scholar
  39. 39.
    Kruger A, Sanchez-Sweatman OH, Martin DC et al. Host TIMP-1 overexpression confers resistance to experimental brain metastasis of a fibrosarcoma cell line. Oncogene 1998; 16: 2419–23.PubMedCrossRefGoogle Scholar
  40. 40.
    Alexander CM, Werb Z. Targeted distruption of the Tissue Inhibitor of Metalloproteinases gene increases the invasive behavior of primitive mesenchimal cells derived from embrionic stem cells in vitro. J. Cell Biol 1992; 118: 727–39.PubMedCrossRefGoogle Scholar
  41. 41.
    Bahr MJ, Vincent KJ, Arthur MJ et al. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: Regulation by activator protein-1 DNA binding proteins. Hepatology 1999; 29: 839–48.PubMedCrossRefGoogle Scholar
  42. 42.
    Martin DC, Sanchez-Sweatman OH, Ho AT et al. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest 1999; 79: 225–34.PubMedGoogle Scholar
  43. 43.
    Overall CM. Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: Comparison with transforming growth factor-beta 1. J Cell Physiol 1995; 164: 17–25.PubMedCrossRefGoogle Scholar
  44. 44.
    Campbell CE, Flenniken AM, Skup D et al. Identification of a serumand phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J Biol Chem 1991; 266: 7199–206.PubMedGoogle Scholar
  45. 45.
    Edwards DR, Waterhouse P, Holman ML et al. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for inducible and constitutive transcripts. Nucleic Acids Res 1986; 14: 8863–78.PubMedGoogle Scholar
  46. 46.
    Logan SK, Garabedian MJ, Campbell CE et al. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 1996; 271: 774–82.PubMedCrossRefGoogle Scholar
  47. 47.
    Bugno M, Graeve L, Gatsios P et al. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res 1995; 23: 5041–7.PubMedGoogle Scholar
  48. 48.
    Trim JE, Samra SK, Arthur MJ et al. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J Biol Chem 2000; 275: 6657–63.PubMedCrossRefGoogle Scholar
  49. 49.
    Stetler-Stevenson WG, Brown PD, Onisto M et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 1990; 265: 13933–8.PubMedGoogle Scholar
  50. 50.
    O-Charoenrat P, Modjtahedi H, Rhys-Evans P et al. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 2000; 60: 1121–8.PubMedGoogle Scholar
  51. 51.
    Shapiro SD, Kobayashi DK, Welgus HG. Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TIMP-1. J Biol Chem 1992; 267: 13890–4.PubMedGoogle Scholar
  52. 52.
    Braunhut SJ, Moses MA. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem 1994; 269: 13472–9.PubMedGoogle Scholar
  53. 53.
    DeClerck YA, Perez N, Shimada H et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52: 701–8.PubMedGoogle Scholar
  54. 54.
    Imren S, Kohn D, Shimada H et al. Overexpression of Tissue Inhibitor of Metalloproteinases-2 by retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res. 1996; 56: 2891–5.PubMedGoogle Scholar
  55. 55.
    Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270: 5331–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Hammani K, Blakis A, Morsette D et al. Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem 1996; 271: 25498–505.PubMedCrossRefGoogle Scholar
  57. 57.
    van den Brule FA, Engel J, Stetler-Stevenson WG et al. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int J Cancer 1992; 52: 653–7.PubMedGoogle Scholar
  58. 58.
    Mann JS, Kindy MS, Hyde JF et al. Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol Reprod 1993; 48: 1006–13.PubMedCrossRefGoogle Scholar
  59. 59.
    Sato T, Ito A, Mori Y et al. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J 1991; 275: 645–50.PubMedGoogle Scholar
  60. 60.
    Wick M, Haronen R, Mumberg D et al. Structure of the human TIMP-3 gene and its cell cycle-regulated promoter. Biochem J 1995; 311: 549–54.PubMedGoogle Scholar
  61. 61.
    Apte SS, Hayashi K, Seldin MF et al. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10. Dev Dyn 1994; 200: 177–97.PubMedGoogle Scholar
  62. 62.
    Weber BH, Vogt G, Pruett RC et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994; 8: 352–6.PubMedCrossRefGoogle Scholar
  63. 63.
    Sun Y, Hegamyer G, Colburn NH. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: One is homologous to human tissue inhibitor of metalloproteinases-3. Cancer Res 1994; 54: 1139–44.PubMedGoogle Scholar
  64. 64.
    Gewert DR, Coulombe B, Castelino M et al. Characterization and expression of a murine gene homologous to human EPA/TIMP: A virus-induced gene in the mouse. Embo J 1987; 6: 651–7.PubMedGoogle Scholar
  65. 65.
    Byrne JA, Tomasetto C, Rouyer N et al. The tissue inhibitor of metalloproteinases-3 gene in breast carcinoma: Identification of multiple polyadenylation sites and a stromal pattern of expression. Mol Med 1995; 1: 418–27.PubMedGoogle Scholar
  66. 66.
    Zeng Y, Rosborough RC, Li Y et al. Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene. Dev Dyn 1998; 211: 228–37.PubMedCrossRefGoogle Scholar
  67. 67.
    Wick M, Burger C, Brusselbach S et al. A novel member of human tissue inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994; 269: 18953–60.PubMedGoogle Scholar
  68. 68.
    Lim MS, Guedez L, Stetler-Stevenson WG et al. Tissue inhibitor of metalloproteinase-2 induces apoptosis in human T lymphocytes. Ann N Y Acad Sci 1999; 878: 522–3.PubMedCrossRefGoogle Scholar
  69. 69.
    Pennie WD, Hegamyer GA, Young MR et al. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells. Cell Growth Differ 1999; 10: 279–86.PubMedGoogle Scholar
  70. 70.
    Bachman KE, Herman JG, Corn PG et al. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res 1999; 59: 798–802.PubMedGoogle Scholar
  71. 71.
    Okamoto Y, Nakano H. Dibutyryl cyclic AMP-induced enhancement of tissue inhibitor of metalloproteinases-3 expression and its possible relation to the invasive activity of the human hepatoma cell line PLC/PRF/5. Anticancer Res 1999; 19: 5175–80.PubMedGoogle Scholar
  72. 72.
    Cameron EE, Bachman KE, Myohanen S et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999; 21: 103–7.PubMedCrossRefGoogle Scholar
  73. 73.
    Warrell RP, Jr., He LZ, Richon V et al. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 1998; 90: 1621–5.PubMedCrossRefGoogle Scholar
  74. 74.
    Baker AH, George SJ, Zaltsman AB et al. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 1999; 79: 1347–55.PubMedCrossRefGoogle Scholar
  75. 75.
    Greene J, Wang M, Liu YE et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271: 30375–80.PubMedCrossRefGoogle Scholar
  76. 76.
    Wang M, Liu YE, Greene J et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 1997; 14: 2767–74.PubMedCrossRefGoogle Scholar
  77. 77.
    Bigg HF, Shi YE, Liu YE et al. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J Biol Chem 1997; 272: 15496–500.PubMedCrossRefGoogle Scholar
  78. 78.
    Li G, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 1999; 59: 6267–75.PubMedGoogle Scholar
  79. 79.
    Guedez L, Stetler-Stevenson WG, Wolff L et al. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998; 102: 2002–10.PubMedGoogle Scholar
  80. 80.
    Barasch J, Yang J, Qiao J et al. Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J Clin Invest 1999; 103: 1299–307.PubMedGoogle Scholar
  81. 81.
    Smith MR, Kung H, Durum SK et al. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997; 9: 770–80.PubMedCrossRefGoogle Scholar
  82. 82.
    Ahonen M, Baker AH, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 1998; 58: 2310–5.PubMedGoogle Scholar
  83. 83.
    Baker AH, Zaltsman AB, George SJ et al. Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or-3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998; 101: 1478–87.PubMedGoogle Scholar
  84. 84.
    George SJ, Lloyd CT, Angelini GD et al. Inhibition of late vein graft neointima formation in human and porcine models by adenovirusmediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 2000; 101: 296–304.PubMedGoogle Scholar
  85. 85.
    Loging WT, Reisman D. Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53. Oncogene 1999; 18: 7608–15.PubMedCrossRefGoogle Scholar
  86. 86.
    Folkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci USA 1998; 95: 9064–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Indraccolo S, Minuzzo S, Gola E et al. Generation of expression plasmids for angiostatin, endostatin and TIMP-2 for cancer gene therapy. Int J Biol Markers 1999; 14: 251–6.PubMedGoogle Scholar
  88. 88.
    Stearns ME, Garcia FU, Fudge K et al. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Clin Cancer Res 1999; 5: 711–20.PubMedGoogle Scholar
  89. 89.
    Fernandez HA, Kallenbach K, Seghezzi G et al. Inhibition of Endothelial Cell Migration by Gene Transfer of Tissue Inhibitor of Metalloproteinases-1. J Surg Res 1999; 82: 156–62.PubMedCrossRefGoogle Scholar
  90. 90.
    Montgomery AM, Mueller BM, Reisfeld RA et al. Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 1994; 54: 5467–73.PubMedGoogle Scholar
  91. 91.
    Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 1995; 14: 908–17.PubMedGoogle Scholar
  92. 92.
    George SJ, Baker AH, Angelini GD et al. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 1998; 5: 1552–60.PubMedCrossRefGoogle Scholar
  93. 93.
    George SJ, Johnson JL, Angelini GD et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smoothmuscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther 1998; 9: 867–77.PubMedGoogle Scholar
  94. 94.
    Yoneda T, Sasaki A, Dunstan C et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 1997; 99: 2509–17.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • Gianfranco Fassina
    • 1
    • 2
  • Nicoletta Ferrari
    • 3
  • Claudio Brigati
    • 3
  • Roberto Benelli
    • 1
  • Leonardo Santi
    • 4
    • 5
  • Douglas M. Noonan
    • 1
  • Adriana Albini
    • 3
  1. 1.Modulo di Progressione NeoplasticaIstituto Nazionale per la Ricerca sul CancroGenoaItaly
  2. 2.Centro di Neurofisiologia CerebraleConsiglio Nazionale delle Ricerca (CNR)GenoaItaly
  3. 3.Laboratorio di Biologia MolecolareIstituto Nazionale per la Ricerca sul CancroGenoaItaly
  4. 4.Dipartimento di Oncologia, Biologia e GeneticaUniversità di GenoaGenoaItaly
  5. 5.CBA, Centro di Biotecnologie AvanzateGenoaItaly

Personalised recommendations